T

The Parkinson's and Movement Disorder Institute | Neurology Department

Research site
(Unclaimed)
Location
9940 Talbert Avenue Suite 100, Fountain Valley, California, United States of America

Site insights

Top conditions

Top treatments

APL-130277
ENT-01
Pimavanserin
Moxifloxacin
PF-06649751
Droxidopa
E2007
Piclozotan
JZP385
Staccato Apomorphine

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 18 total trials
Locations recently updated

A Study of Lu AF82422 in Participants With Multiple System Atrophy (AMULET)

To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

Active, not recruiting
Multiple System Atrophy
Drug: Placebo
Drug: Lu AF82422

This is a 12-week, double-blind, placebo-controlled, randomized, parallel-group, multicenter study of the safety and efficacy of JZP385 in the treatm...

Active, not recruiting
Essential Tremor
Drug: JZP385
Other: Placebo
Locations recently updated

This is a Phase 3, multi-center, randomized withdrawal study to evaluate the efficacy and durability of ampreloxetine in participants with MSA and sy...

Enrolling
MSA - Multiple System Atrophy
Symptomatic Neurogenic Orthostatic Hypotension
Drug: Ampreloxetine
Drug: Placebo

Trial sponsors

Sumitomo Pharma logo
E
Ipsen logo
Lundbeck logo
Acadia Pharmaceuticals logo
Alexza Pharmaceuticals logo
Daiichi Sankyo logo
Eisai logo
I
Jazz Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems